Table of Contents
Table of Contents 2


Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Clinical Trials by G7 Countries: Proportion of Pheochromocytoma to Oncology Clinical Trials 11
Clinical Trials by Phase in G7 Countries 12
Clinical Trials in G7 Countries by Trial Status 13
Clinical Trials by E7 Countries: Proportion of Pheochromocytoma to Oncology Clinical Trials 14
Clinical Trials by Phase in E7 Countries 15
Clinical Trials in E7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Pheochromocytoma Therapeutics Clinical Trials 24
Prominent Drugs 26
Clinical Trial Profile Snapshots 27
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 70

List of Tables
Pheochromocytoma Therapeutics, Global, Clinical Trials by Region, 2016* 5
Pheochromocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Pheochromocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Pheochromocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 8
Pheochromocytoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9
Pheochromocytoma Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
Proportion of Pheochromocytoma to Oncology Clinical Trials, G7 Countries (%), 2016* 11
Pheochromocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12
Pheochromocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 13
Proportion of Pheochromocytoma to Oncology Clinical Trials, E7 Countries (%), 2016* 14
Pheochromocytoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 15
Pheochromocytoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 16
Pheochromocytoma Therapeutics, Global, Clinical Trials by Phase, 2016* 17
Pheochromocytoma Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 18
Pheochromocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
Pheochromocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
Pheochromocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
Pheochromocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22
Pheochromocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
Pheochromocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25
Pheochromocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26

List of Figures
Pheochromocytoma Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Pheochromocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Pheochromocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Pheochromocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 8
Pheochromocytoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 9
Pheochromocytoma Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10
Proportion of Pheochromocytoma to Oncology Clinical Trials, G7 Countries (%), 2016* 11
Pheochromocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12
Pheochromocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 13
Proportion of Pheochromocytoma to Oncology Clinical Trials, E7 Countries (%), 2016* 14
Pheochromocytoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 15
Pheochromocytoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 16
Pheochromocytoma Therapeutics, Global, Clinical Trials by Phase (%), 2016* 17
Pheochromocytoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 18
Pheochromocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
Pheochromocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
Pheochromocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
Pheochromocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22
Pheochromocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
Pheochromocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24
Pheochromocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26
GlobalData Methodology 68